Core Viewpoint - The announcement from United Imaging Healthcare (联影医疗) regarding the planned share reduction by its employee stockholding platforms indicates a need for liquidity, despite the company's recent performance showing signs of recovery in early 2025 [1][5]. Group 1: Share Reduction Details - Five employee stockholding platforms plan to reduce a total of up to 13,376,600 shares, representing 1.6231% of the total share capital [2]. - The reduction period is set from August 25, 2025, to November 24, 2025, with the shares being acquired before the IPO [2]. - The total shares held by these platforms before the reduction was 54,584,400, which accounted for 6.62% of the total share capital, expected to drop below 5% post-reduction [1][2]. Group 2: Financial Performance - In 2024, United Imaging Healthcare reported total revenue of 10.3 billion yuan, a decrease of 9.73% year-on-year, and a net profit of 1.262 billion yuan, down 36.08% year-on-year [3]. - The company experienced its first annual decline in both revenue and net profit since its performance disclosures began in 2018 [2][3]. - Despite domestic market challenges, the company achieved a 35.07% year-on-year growth in overseas business revenue, totaling 2.266 billion yuan, which constituted 22% of total revenue [3]. Group 3: Market Position and Future Outlook - United Imaging Healthcare holds the top market share in China's imaging products (excluding ultrasound and DSA) for 2024, with first place in CT, MI, and diagnostic XR products, and second in MR products [6]. - The company is increasing its R&D investment, with 568 million yuan allocated in Q1 2025, a 12.01% increase year-on-year, representing 22.92% of total revenue [5]. - The stock price showed a decline of 1.52% following the announcement of the share reduction plan, closing at 131.29 yuan per share on August 4, 2025 [6].

大股东及其一致行动人、董监高过去12个月内减持股份情况如下： | 减持数量 股东名称 减持期间 | 減持 | | 减持价格区间 前期减持计 | | | --- | --- | --- | --- | --- | | (股) | 比例 | | (元/股) 划披露日期 | | | 宁波影聚、宁波影力、宁波 7,471,530 0.91% 2024/4/15~ | | 102.60-140.37 2024年3月 | | | | 2024/7/22 影健、宁波影康、上海影董 | | | | 30 日 | 以减持价格区间计算，公司员工持股平台去年减持套现76657.90万元至104877.87万元。如以减持期间加 权均价118.86元计算，套现金额为88806.61万元。 联影医疗2024年度年报显示，联影集团为公司控股股东，联影集团董事长薛敏为实际控制人。前十大股 东中，宁波影力、宁波影康和宁波影健均系公司员工持股平台，其执行事务合伙人均为张强。 联影医疗董事长张强为联影集团董事，并担任上海影董、宁波影聚、宁波影力、宁波影健、宁波影康执 行事务合伙人。 中国经济网北京8月4日讯联影医疗(688271.SH)昨晚发布股 ...

Group 1: Haohan Depth - Haohan Convertible Bond (118052) is set to be listed on April 7, 2025 [1] - The company's subsidiary, Nanjing Youzhu Information Technology Co., Ltd., has established a "Low-altitude Airspace Safety Technology Innovation Joint Laboratory" in collaboration with China Telecom Design Institute, Nanjing University, and Jinling Institute of Technology [1] - The company's DPI technology and related cybersecurity solutions are designed to identify risks, recognize threats, block attacks, and protect data and privacy, effectively ensuring overall security in the Internet of Vehicles, including vehicle-side, roadside, cloud-side, and platform security [1] Group 2: Xingye Silver Tin - The recent research involved the progress of Yinman Phase II, the expansion of Yubang Mining, the injection arrangement of Budun Silver Mine, and the company's development strategy [1] - Yinman Phase II has received project approval and is in communication with the government for construction permits; Yubang Mining's 8.25 million ton expansion project is applying for construction permits [1] - The company focuses on silver and tin as core businesses while steadily integrating copper and gold resources; the Yubang Mining expansion project is expected to produce 450 tons of silver annually upon reaching full capacity [1] - The company has established a comprehensive safety management system, emphasizing safety funding investment and promoting mechanization, automation, informationization, and intelligence construction [1] - The mining areas of Yinman and Yubang show promising mineralization, with good exploration prospects for the Morocco project [1]

000558 天府文旅 B004 000826 启迪环境 B001 000998 隆平高科 B001 001236 弘业期货 A07 001314 亿道信息 A06 001324 长青科技 A06 002037 保利联合 A06 002198 嘉应制药 A07 002219 新里程 B001 002330 得利斯 B007 002408 齐翔腾达 B003 002424 贵州百灵 A07 002600 领益智造 B007 002629 仁智股份 A07 002634 棒杰股份 A07 002716 湖南白银 A06 002775 文科股份 B004 002799 环球印务 A07 002921 联诚精密 A07 002940 昂利康 B004 002951 金时科技 A06 300691 联合光电 A06 301632 广东建科 A08 600009 上海机场 A08 600031 三一重工 A08 600104 上汽集团 A08 600166 福田汽车 B003 600507 方大特钢 B001 平安基金 B003 融通基金 B007 上银基金 B005 天弘基金 B006 太平基金 B005 信达证券基金 ...

上述股份系其在首次公开发行前取得的股份，已于2023年8月22日起上市流通。 登录新浪财经APP 搜索【信披】查看更多考评等级 ● 减持计划的主要内容 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 股东持股的基本情况 本次减持计划实施前，上海联影医疗科技股份有限公司（以下简称"公司"或"联影医疗"）股东宁波梅山 保税港区影聚投资管理合伙企业（有限合伙）（以下简称"宁波影聚"）持有公司股份11,145,243股，占 公司总股本的1.35%；宁波梅山保税港区影力投资管理合伙企业（有限合伙）（以下简称"宁波影力"） 持有公司股份12,411,182股，占公司总股本的1.51%；宁波梅山保税港区影健投资管理合伙企业（有限 合伙）（以下简称"宁波影健"）持有公司股份12,411,182股，占公司总股本的1.51%；宁波梅山保税港区 影康投资管理合伙企业（有限合伙）（以下简称"宁波影康"）持有公司股份12,411,182股，占公司总股 本的1.51%；上海影董企业管理合伙企业（有限合伙）（以下简称"上海 ...

截至2025年8月1日收盘，联影医疗(688271)报收于133.31元，上涨0.01%，换手率0.46%，成交量2.74万 手，成交额3.66亿元。 当日关注点 交易信息汇总 8月1日，联影医疗的资金流向显示，主力资金净流出974.32万元，占总成交额的2.66%；游资资金净流 入1295.19万元，占总成交额的3.54%；散户资金净流出320.87万元，占总成交额的0.88%。 公司公告汇总 联影医疗发布股东减持股份计划公告。公告指出，宁波梅山保税港区影聚投资管理合伙企业等五家股东 合计持有公司股份54584379股，占公司总股本的6.62%。这些股份系首次公开发行前取得，并于2023年 8月22日起上市流通。员工持股平台计划通过大宗交易或集中竞价方式合计减持联影医疗股份不超过 13376600股，不超过总股本的1.6231%，实际减持数量以员工按月提出出售申请后汇总的数据为准，减 持价格参考市场价格。减持期间为2025年8月25日至2025年11月24日。员工持股平台承诺自公司股票上 市之日起12个月内不转让或委托管理所持股份。公司表示，本次减持计划不会对公司治理、持续性经营 产生影响，不存在导致公司控 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688271 证券简称：联影医疗 公告编号：2025-030 上海联影医疗科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 股东持股的基本情况 本次减持计划实施前，上海联影医疗科技股份有限公司（以下简称"公司"或"联影医疗"）股东宁波梅山 保税港区影聚投资管理合伙企业（有限合伙）（以下简称"宁波影聚"）持有公司股份11,145,243股，占 公司总股本的1.35%；宁波梅山保税港区影力投资管理合伙企业（有限合伙）（以下简称"宁波影力"） 持有公司股份12,411,182股，占公司总股本的1.51%；宁波梅山保税港区影健投资管理合伙企业（有限 合伙）（以下简称"宁波影健"）持有公司股份12,411,182股，占公司总股本的1.51%；宁波梅山保税港区 影康投资管理合伙企业（有限合伙）（以下简称"宁波影康"）持有公司股份12,411,182股，占公司总股 本的1.51%；上海影董企业管理合伙企业（有限 ...

证券代码：688271 证券简称：联影医疗 公告编号：2025-030 上海联影医疗科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 股东持股的基本情况 本次减持计划实施前，上海联影医疗科技股份有限公司（以下简称"公司" 或"联影医疗"）股东宁波梅山保税港区影聚投资管理合伙企业（有限合伙） （以 下简称"宁波影聚"）持有公司股份 11,145,243 股，占公司总股本的 1.35%；宁 波梅山保税港区影力投资管理合伙企业（有限合伙） （以下简称"宁波影力"）持 有公司股份 12,411,182 股，占公司总股本的 1.51%；宁波梅山保税港区影健投 资管理合伙企业（有限合伙） （以下简称"宁波影健"）持有公司股份 12,411,182 股，占公司总股本的 1.51%；宁波梅山保税港区影康投资管理合伙企业（有限合 伙） （以下简称"宁波影康"）持有公司股份 12,411,182 股，占公司总股本的 1.51%； 上海影董企业管理合伙企业（有限合伙）（以下简 ...

Core Viewpoint - On August 3, no A-share listed companies disclosed any increase in shareholding, while 13 companies announced share reductions, indicating a trend of shareholder divestment in the market [1]. Group 1: Companies with Share Reductions - Guo An Guo Ji: Independent director Yang Deli plans to reduce holdings by no more than 5,000 shares [2]. - Changqing Technology: Shareholders plan to collectively reduce holdings by up to 5.98% of the company's shares [2]. - Zhongqi New Materials: Shareholders will reduce holdings by no more than 3% of the company's shares [2]. - Bangjie Shares: Shareholders Shanghai Fangyuan and Zhejiang Dianchuang plan to reduce their holdings [2]. - Huayi: Shareholder holding over 5% intends to reduce holdings by no more than 1% of the company's shares [2]. - Gaoling Information: Shareholders plan to reduce holdings by no more than 2.42% of the company's shares [2]. - Renzhi Shares: Directors and senior management plan to reduce holdings by no more than 2.8 million shares [2]. - Zhongshe Shares: Lu Weidong and Yuan Yijun plan to reduce holdings by no more than 0.4332% and 0.1509% of shares, respectively [2]. - Daoming Optical: Shareholder Hu Huiling plans to reduce holdings by no more than 0.48% of the company's shares [2]. - United Imaging Healthcare: Employee stock ownership platform plans to reduce holdings by no more than 1.6231% of the company's shares [2]. - Lijing Navigation: Shareholders and their concerted actions plan to reduce holdings by no more than 3% of the company's shares [2]. - Chenfeng Technology: Xizhou Yunda plans to reduce holdings by no more than 1% of shares [2]. - Fangda Special Steel: Shareholder Xu Hui plans to reduce holdings by no more than 1% of the company's shares [2].

Core Viewpoint - The news highlights various companies' recent activities, including share buybacks, acquisitions, refinancing, and operational updates, indicating a mixed performance across different sectors. Group 1: Company Performance and Activities - Angli Kang currently has only one innovative drug project under research [1] - Sany Heavy Industry has repurchased a total of 72.6792 million shares, with a total payment of 1.355 billion yuan [3] - Mingpu Guangmi plans to acquire 60% of Shenzhen ABB Electric Transportation Technology Co., Ltd. for approximately 118 million yuan [3] - Jinlang Technology has received approval from the Shenzhen Stock Exchange for issuing convertible bonds to unspecified investors [3] - Guangan Aizhong expects to reduce its net profit attributable to shareholders by approximately 39.38 million yuan due to the implementation of low valley period electricity pricing policy [4] Group 2: Clinical Research and Legal Issues - Watson Bio's clinical research application for a respiratory syncytial virus mRNA vaccine has been accepted [5] - ST Pava's co-actual controller and director Zhang Bao is under investigation by public security for suspected embezzlement [5] Group 3: Production and Sales Updates - Qixiang Tengda has resumed production at its 300,000 tons/year propylene oxide facility [6] - Gold Open New Energy's subsidiary has completed the overall delivery of the first phase of a computing power cluster [7] - SAIC Motor's vehicle sales in July reached 337,500 units, a year-on-year increase of 34.2% [9] - BAIC Blue Valley's July sales decreased by 6.38% year-on-year [9] Group 4: Shareholder Actions and Corporate Changes - Shareholders of various companies, including Xu Huigong of Fangda Special Steel and employees of United Imaging Healthcare, plan to reduce their holdings by up to 1% to 5.98% [9] - Jiachuan Vision's controlling shareholder is planning a change in company control, leading to a stock suspension [9] - Jinshi Technology intends to publicly transfer 100% equity of its wholly-owned subsidiary Hunan Jinshi [9] - Liying Intelligent Manufacturing's restructuring matter will be reviewed by the Shenzhen Stock Exchange on August 8 [9] - Chip Guide Technology plans to acquire 100% of Jishun Technology and 17.15% of Shunlei Technology [9] Group 5: Name Changes and Pricing Adjustments - Danhua Technology will change its stock name to Jinmei Technology starting August 7 [10] - Leshan Electric Power expects an increase in gas sales gross profit of approximately 2.7 million yuan for the year 2025 due to price adjustments [10]